The WACC of Karyopharm Therapeutics Inc (KPTI) is 6.5%.
| Range | Selected | |
| Cost of equity | 8.20% - 12.40% | 10.30% |
| Tax rate | 0.20% - 0.20% | 0.20% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 4.9% - 8.1% | 6.5% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.95 | 1.34 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.20% | 12.40% |
| Tax rate | 0.20% | 0.20% |
| Debt/Equity ratio | 3.64 | 3.64 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 4.9% | 8.1% |
| Selected WACC | 6.5% | |